Literature DB >> 12270684

Gene expression profiles in a transgenic animal model of fragile X syndrome.

Velia D'Agata1, Stephen T Warren, Weiqin Zhao, Enrique R Torre, Daniel L Alkon, Sebastiano Cavallaro.   

Abstract

Fragile X syndrome is the most common inherited form of mental retardation. Although this syndrome originates from the absence of the RNA-binding protein FMRP, the molecular mechanisms underlying the cognitive deficits are unknown. The expression pattern of 6789 genes was studied in the brains of wild-type and FMR1 knockout mice, a fragile X syndrome animal model that has been associated with cognitive deficits. Differential expression of more than two-fold was observed for the brain mRNA levels of 73 genes. Differential expression of nine of these genes was confirmed by real-time quantitative reverse transcription-polymerase chain reaction and by in situ hybridization. In addition to corroborating the microarray data, the in situ hybridization analysis showed distinct spatial distribution patterns of microtubule-associated protein 2 and amyloid beta precursor protein. A number of differentially expressed genes associated with the fragile X syndrome phenotype have been previously involved in other memory or cognitive disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270684     DOI: 10.1006/nbdi.2002.0506

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  14 in total

1.  Memory-specific temporal profiles of gene expression in the hippocampus.

Authors:  Sebastiano Cavallaro; Velia D'Agata; Pachiappan Manickam; Franck Dufour; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

2.  Genomic portraits of the nervous system in health and disease.

Authors:  Velia D'Agata; Sebastiano Cavallaro
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

3.  Mining microarrays for metabolic meaning: nutritional regulation of hypothalamic gene expression.

Authors:  Charles V Mobbs; Kelvin Yen; Jason Mastaitis; Ha Nguyen; Elizabeth Watson; Elisa Wurmbach; Stuart C Sealfon; Andrew Brooks; Stephen R J Salton
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

4.  Molecular and genetic analysis of the Drosophila model of fragile X syndrome.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Results Probl Cell Differ       Date:  2012

Review 5.  Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.

Authors:  D K Sokol; B Maloney; J M Long; B Ray; D K Lahiri
Journal:  Neurology       Date:  2011-04-12       Impact factor: 9.910

Review 6.  Fragile X Syndrome and Alzheimer's Disease: Another story about APP and beta-amyloid.

Authors:  J S Malter; B C Ray; P R Westmark; C J Westmark
Journal:  Curr Alzheimer Res       Date:  2010-05       Impact factor: 3.498

7.  Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Authors:  Edouard W Khandjian; Marc-Etienne Huot; Sandra Tremblay; Laetitia Davidovic; Rachid Mazroui; Barbara Bardoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

8.  Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice.

Authors:  Lujian Liao; Sung Kyu Park; Tao Xu; Peter Vanderklish; John R Yates
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

9.  Seizure susceptibility and mortality in mice that over-express amyloid precursor protein.

Authors:  Cara J Westmark; Pamela R Westmark; Ashley M Beard; Sharon M Hildebrandt; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

10.  Whole genome microarray analysis of gene expression in subjects with fragile X syndrome.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Merlin G Butler
Journal:  Genet Med       Date:  2007-07       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.